Brittany Yerkes
Physician Assistant · Salisbury, MDNPI 1336425206
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $55,830 of the $81,057 with a category attached, or 68.9%. Viiv Healthcare Company accounts for 63.1% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $37,262, more than ten times the $403 reported in 2021. Among physician assistant clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 335 payments — averaging $241.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$51K
- Gilead$28K
- Merck$307
- AbbVie$280
- Exact Sciences$126
- Abbott$114
- plus $888 from 16 others
What the payments were for
- Consulting fees$2,1003%
- Speaking & faculty fees$55,83069%
- Travel & lodging$14,80118%
- Food & beverage$8,32510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 134 | $51,116 |
| Gilead | 118 | $28,226 |
| Merck | 15 | $307 |
| AbbVie | 8 | $280 |
| Exact Sciences | 5 | $126 |
| Abbott | 6 | $114 |
| Insulet Corporation | 5 | $113 |
| Phathom Pharmaceuticals, Inc. | 6 | $103 |
| Lilly USA, LLC | 5 | $100 |
| Novo Nordisk | 6 | $96 |
| Pfizer | 4 | $79 |
| Bayer | 4 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $62 |
| Boehringer Ingelheim | 3 | $55 |
| AstraZeneca | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| GSK | 2 | $36 |
| Corcept Therapeutics | 1 | $33 |
| Dexcom, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$81,057 in reported general payments places this provider in the 95th percentile of 2,567 physician assistant providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 305 | $1,209,298 |
| TivicayDolutegravir Sodium | 133 | $418,654 |
| CabenuvaCabotegravir/Rilpivirine | 48 | $310,662 |
| DovatoDolutegravir Sodium/Lamivudine | 66 | $193,744 |
| JulucaDolutegravir/Rilpivirine | 46 | $161,715 |
| PrezcobixDarunavir/Cobicistat | 49 | $122,686 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 36 | $121,051 |
| DescovyEmtricitabine/Tenofov Alafenam | 56 | $116,784 |
| RukobiaFostemsavir Tromethamine | 11 | $92,330 |
| PifeltroDoravirine | 49 | $83,656 |
| JardianceEmpagliflozin | 55 | $46,513 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 11 | $40,640 |
| EliquisApixaban | 37 | $29,236 |
| OzempicSemaglutide | 31 | $28,225 |
| Spiriva RespimatTiotropium Bromide | 24 | $13,679 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $28,226 | $1,326,081361 claims |
| Viiv Healthcare CompanyTivicay, Cabenuva, Dovato, Juluca, Rukobia | $51,116 | $1,217,745315 claims |
| MerckPifeltro, Januvia, Belsomra | $307 | $103,74785 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat | $55 | $66,10291 claims |
| PfizerEliquis | $79 | $29,23637 claims |
| Novo NordiskOzempic | $96 | $28,22531 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $47 | $20,79235 claims |
| Lilly USA, LLCTrulicity | $100 | $13,33614 claims |
| GSKArnuity Ellipta | $36 | $4,18916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Salisbury
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
- Lisa FoxAnnapolis$26K
- Praveena GadamBaltimore$24K
- Jinhui YuanFrederick$21K
- Lisa GallucciRockville$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.